Trial intelligence / Profile preview

ACE inhibitors and angiotensin II receptor antagonists in IgA nephropathy with mild proteinuria

2005-003885-40Phase 3Terminated

Sponsor
ASST Lecco
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ramipril and irbesartan in IgA nephropathy (IgAN) (3 arms), sponsored by ASST Lecco. Started Jan 2007; status: terminated.

02

Drugs

ramiprilirbesartan
03

Conditions

IgA nephropathy (IgAN)

Beyond the preview

Go deeper on 2005-003885-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003885-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call